Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center.

Blitzer GC, Rosenberg SA, Anderson BM, McCulloch TM, Wieland AM, Hartig GK, Bruce JY, Witek ME, Kimple RJ, Harari PM.

Int J Radiat Oncol Biol Phys. 2018 Jul 3. pii: S0360-3016(18)30800-9. doi: 10.1016/j.ijrobp.2018.05.007. [Epub ahead of print] No abstract available.

PMID:
29980415
2.

The Resident Individual Development Plan as a Guide for Radiation Oncology Mentorship.

Ko HC, Kimple RJ.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):786-788. doi: 10.1016/j.ijrobp.2018.02.153. Epub 2018 Mar 6. No abstract available.

PMID:
29976489
3.

Beyond 'charting outcomes' in the radiation oncology match: analysis of self-reported applicant data.

Jang S, Rosenberg SA, Hullett C, Bradley KA, Kimple RJ.

Med Educ Online. 2018 Dec;23(1):1489691. doi: 10.1080/10872981.2018.1489691.

4.

Corrigendum: Potential role of the glycolytic oscillator in acute hypoxia in tumors (2015 Phys. Med. Biol. 60 9215).

Che Fru L, Adamson EB, Campos DD, Fain SB, Jacques SL, van der Kogel AJ, Nickel KP, Song C, Kimple RJ, Kissick MW.

Phys Med Biol. 2018 Jun 6. doi: 10.1088/1361-6560/aacaba. [Epub ahead of print]

PMID:
29873307
5.

In Reply to Hamstra.

Rosenberg SA, Bradley KA, Kimple RJ.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1293-1294. doi: 10.1016/j.ijrobp.2018.01.038. No abstract available.

PMID:
29722667
6.

Identity Crisis - Rigor and Reproducibility in Human Cell Lines.

Eckers JC, Swick AD, Kimple RJ.

Radiat Res. 2018 Jun;189(6):551-552. doi: 10.1667/RR15086.1. Epub 2018 Apr 13. No abstract available.

PMID:
29652622
7.

Genomics Reloaded: Rise of the Expression Profiles.

Gan GN, Kimple RJ.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):1-3. doi: 10.1016/j.ijrobp.2017.10.023. No abstract available.

PMID:
29619961
8.

Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.

Davidson SM, Ko HC, Harari PM, Wieland AM, Chen S, Baschnagel AM, Kimple RJ, Witek AME.

Otolaryngol Head Neck Surg. 2018 Apr 1:194599818766035. doi: 10.1177/0194599818766035. [Epub ahead of print]

PMID:
29611770
9.

Value of Elective Radiation Oncology Rotations: How Many Is Too Many?

Jang S, Rosenberg SA, Hullet C, Bradley KA, Kimple RJ.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):558-559. doi: 10.1016/j.ijrobp.2017.10.052. Epub 2017 Nov 6. No abstract available.

PMID:
29413271
10.

Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report and review of the literature.

Gallagher SJ, Rosenberg SA, Francis D, Salamat S, Howard SP, Kimple RJ.

Clin Neurol Neurosurg. 2018 Feb;165:76-80. doi: 10.1016/j.clineuro.2017.12.014. Epub 2018 Jan 6. Review.

PMID:
29324399
11.

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.

Redlich N, Robinson AM, Nickel KP, Stein AP, Wheeler DL, Adkins DR, Uppaluri R, Kimple RJ, Van Tine BA, Michel LS.

Cell Death Dis. 2018 Jan 5;9(1):5. doi: 10.1038/s41419-017-0029-0.

12.

Biological characterization of a novel in vitro cell irradiator.

Fowler TL, Fisher MM, Bailey AM, Bednarz BP, Kimple RJ.

PLoS One. 2017 Dec 12;12(12):e0189494. doi: 10.1371/journal.pone.0189494. eCollection 2017.

13.

The Second Stain: A Viral Whodunnit.

Rosenberg SA, Kimple RJ.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1061. doi: 10.1016/j.ijrobp.2017.05.027. No abstract available.

PMID:
29165273
14.

The Future of Radiobiology.

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ.

J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231.

PMID:
29126306
15.

Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.

Pearson HE, Iida M, Orbuch RA, McDaniel NK, Nickel KP, Kimple RJ, Arbiser JL, Wheeler DL.

Mol Cancer Ther. 2018 Jan;17(1):204-214. doi: 10.1158/1535-7163.MCT-17-0384. Epub 2017 Oct 20.

16.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.

Ko HC, Harari PM, Chen S, Wieland AM, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1126-1133. doi: 10.1001/jamaoto.2017.1756.

PMID:
29049434
17.

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Ko HC, Harari PM, Sacotte RM, Chen S, Wieland AM, Yu M, Baschnagel AM, Bruce JY, Kimple RJ, Witek ME.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350. doi: 10.1007/s00432-017-2481-8. Epub 2017 Jul 27.

PMID:
28752235
18.

Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition.

Prabakaran PJ, Javaid AM, Swick AD, Werner LR, Nickel KP, Sampene E, Hu R, Ong IM, Bruce JY, Hartig GK, Wieland AM, Canon J, Harari PM, Kimple RJ.

Clin Cancer Res. 2017 Oct 15;23(20):6044-6053. doi: 10.1158/1078-0432.CCR-17-0969. Epub 2017 Jun 28.

PMID:
28659312
19.

Small cell carcinoma of the head and neck: An analysis of the National Cancer Database.

Pointer KB, Ko HC, Brower JV, Witek ME, Kimple RJ, Lloyd RV, Harari PM, Baschnagel AM.

Oral Oncol. 2017 Jun;69:92-98. doi: 10.1016/j.oraloncology.2017.04.009. Epub 2017 Apr 25.

20.

Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.

Jang S, Patel PN, Kimple RJ, McCulloch TM.

Anticancer Res. 2017 Jun;37(6):3045-3052.

PMID:
28551643
21.

Potential Mechanisms of Vascular Thrombosis after Microwave Ablation in an in Vivo Liver.

Chiang J, Nickel K, Kimple RJ, Brace CL.

J Vasc Interv Radiol. 2017 Jul;28(7):1053-1058. doi: 10.1016/j.jvir.2017.03.034. Epub 2017 Apr 26.

22.

Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.

Swick AD, Prabakaran PJ, Miller MC, Javaid AM, Fisher MM, Sampene E, Ong IM, Hu R, Iida M, Nickel KP, Bruce JY, Wheeler DL, Kimple RJ.

Mol Cancer Ther. 2017 Jul;16(7):1257-1268. doi: 10.1158/1535-7163.MCT-17-0115. Epub 2017 Apr 26.

23.

The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.

Brand TM, Iida M, Corrigan KL, Braverman CM, Coan JP, Flanigan BG, Stein AP, Salgia R, Rolff J, Kimple RJ, Wheeler DL.

Sci Signal. 2017 Jan 3;10(460). pii: eaag1064. doi: 10.1126/scisignal.aag1064.

PMID:
28049763
24.

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease.

Witek ME, Wieland AM, Chen S, Kennedy TA, Hullett CR, Liang E, Hartig GK, Kimple RJ, Harari PM.

Cancers Head Neck. 2017;2. pii: 8. doi: 10.1186/s41199-017-0027-z. Epub 2017 Nov 14.

25.

Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.

Swick AD, Stein AP, McCulloch TM, Hartig GK, Ong IM, Sampene E, Prabakaran PJ, Liu CZ, Kimple RJ.

Oral Oncol. 2017 Jan;64:65-72. doi: 10.1016/j.oraloncology.2016.11.017. Epub 2016 Dec 8.

26.

Online patient information from radiation oncology departments is too complex for the general population.

Rosenberg SA, Francis DM, Hullet CR, Morris ZS, Brower JV, Anderson BM, Bradley KA, Bassetti MF, Kimple RJ.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):57-62. doi: 10.1016/j.prro.2016.07.008. Epub 2016 Aug 1.

27.

Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.

Brower JV, Amini A, Chen S, Hullett CR, Kimple RJ, Wojcieszynski AP, Bassetti M, Witek ME, Yu M, Harari PM, Baschnagel AM.

Ann Oncol. 2016 Oct;27(10):1887-94. doi: 10.1093/annonc/mdw276. Epub 2016 Aug 8.

PMID:
27502703
28.

Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.

Iida M, Bahrar H, Brand TM, Pearson HE, Coan JP, Orbuch RA, Flanigan BG, Swick AD, Prabakaran PJ, Lantto J, Horak ID, Kragh M, Salgia R, Kimple RJ, Wheeler DL.

Mol Cancer Ther. 2016 Sep;15(9):2175-86. doi: 10.1158/1535-7163.MCT-16-0012. Epub 2016 Jul 15.

29.

Readability of Online Patient Educational Resources Found on NCI-Designated Cancer Center Web Sites.

Rosenberg SA, Francis D, Hullett CR, Morris ZS, Fisher MM, Brower JV, Bradley KA, Anderson BM, Bassetti MF, Kimple RJ.

J Natl Compr Canc Netw. 2016 Jun;14(6):735-40.

PMID:
27283166
30.

Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.

Campos D, Peeters W, Nickel K, Burkel B, Bussink J, Kimple RJ, van der Kogel A, Eliceiri KW, Kissick MW.

Radiat Res. 2016 May;185(5):496-504. doi: 10.1667/RR14093.1. Epub 2016 Apr 29.

31.

Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.

Romick-Rosendale LE, Hoskins EE, Privette Vinnedge LM, Foglesong GD, Brusadelli MG, Potter SS, Komurov K, Brugmann SA, Lambert PF, Kimple RJ, Virts EL, Hanenberg H, Gillison ML, Wells SI.

Clin Cancer Res. 2016 Apr 15;22(8):2062-73. doi: 10.1158/1078-0432.CCR-15-2209. Epub 2015 Nov 24.

32.

Potential role of the glycolytic oscillator in acute hypoxia in tumors.

Fru LC, Adamson EB, Campos DD, Fain SB, Jacques SL, van der Kogel AJ, Nickel KP, Song C, Kimple RJ, Kissick MW.

Phys Med Biol. 2015 Dec 21;60(24):9215-25. doi: 10.1088/0031-9155/60/24/9215. Epub 2015 Nov 18.

33.

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models.

Francis DM, Huang S, Armstrong EA, Werner LR, Hullett C, Li C, Morris ZS, Swick AD, Kragh M, Lantto J, Kimple RJ, Harari PM.

Clin Cancer Res. 2016 Feb 1;22(3):633-43. doi: 10.1158/1078-0432.CCR-15-1664. Epub 2015 Sep 29.

34.

Modulation of therapeutic sensitivity by human papillomavirus.

Swick AD, Chatterjee A, De Costa AM, Kimple RJ.

Radiother Oncol. 2015 Sep;116(3):342-5. doi: 10.1016/j.radonc.2015.09.002. Epub 2015 Sep 10. Review.

35.

Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.

Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM.

Radiother Oncol. 2015 Sep;116(3):504-9. doi: 10.1016/j.radonc.2015.06.015. Epub 2015 Jun 26.

36.

Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience.

Liang E, Brower JV, Rice SR, Buehler DG, Saha S, Kimple RJ.

PLoS One. 2015 Jun 8;10(6):e0129476. doi: 10.1371/journal.pone.0129476. eCollection 2015.

37.

Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF, Kimple RJ.

Cancer J. 2015 May-Jun;21(3):138-46. doi: 10.1097/PPO.0000000000000115. Review.

38.

The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

Kimple RJ, Harari PM.

Ann Transl Med. 2015 May;3(Suppl 1):S14. doi: 10.3978/j.issn.2305-5839.2015.01.37. No abstract available.

39.

Human papillomavirus and head and neck cancer.

Kimple RJ, Sher DJ.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):196-9. doi: 10.1016/j.ijrobp.2015.01.015. No abstract available.

PMID:
25968816
40.

Acute Toxicity From Breast Cancer Radiation Using Helical Tomotherapy With a Simultaneous Integrated Boost.

Wojcieszynski AP, Olson AK, Rong Y, Kimple RJ, Yadav P.

Technol Cancer Res Treat. 2016 Apr;15(2):257-65. doi: 10.1177/1533034615574387. Epub 2015 Mar 16.

PMID:
25780060
41.

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.

Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL.

Clin Cancer Res. 2015 Jun 1;21(11):2601-12. doi: 10.1158/1078-0432.CCR-14-2648. Epub 2015 Mar 12.

42.

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies.

Stein AP, Swick AD, Smith MA, Blitzer GC, Yang RZ, Saha S, Harari PM, Lambert PF, Liu CZ, Kimple RJ.

Cancer Med. 2015 May;4(5):699-712. doi: 10.1002/cam4.387. Epub 2015 Jan 26.

43.

High-throughput detection of DNA double-strand breaks using image cytometry.

Fowler TL, Bailey AM, Bednarz BP, Kimple RJ.

Biotechniques. 2015 Jan 1;58(1):37-9. doi: 10.2144/000114248. eCollection 2015 Jan.

44.

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.

Zhang K, Jones L, Lim S, Maher CA, Adkins D, Lewis J, Kimple RJ, Fertig EJ, Chung CH, Van Tine BA, Ellis MJ, Herrlich A, Michel LS.

Oncotarget. 2014 Oct 15;5(19):9281-94.

45.

Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.

Park JW, Nickel KP, Torres AD, Lee D, Lambert PF, Kimple RJ.

Radiother Oncol. 2014 Dec;113(3):337-44. doi: 10.1016/j.radonc.2014.08.026. Epub 2014 Sep 9.

46.

AXL mediates resistance to cetuximab therapy.

Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL.

Cancer Res. 2014 Sep 15;74(18):5152-64. doi: 10.1158/0008-5472.CAN-14-0294. Epub 2014 Aug 18.

47.

Wetting the whistle: neurotropic factor improves salivary function.

Swick A, Kimple RJ.

J Clin Invest. 2014 Aug;124(8):3282-4. doi: 10.1172/JCI77194. Epub 2014 Jul 18.

48.

Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts.

Stein AP, Saha S, Liu CZ, Hartig GK, Lambert PF, Kimple RJ.

PLoS One. 2014 Jun 26;9(6):e100995. doi: 10.1371/journal.pone.0100995. eCollection 2014.

49.

Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time.

Stein AP, Saha S, Yu M, Kimple RJ, Lambert PF.

Chem Res Toxicol. 2014 Apr 21;27(4):462-9. doi: 10.1021/tx500034c. Epub 2014 Apr 2.

50.

DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.

Adams AK, Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, Wikenheiser-Brokamp KA, Wise-Draper TM, Wells SI.

Oncogene. 2015 Feb 12;34(7):868-77. doi: 10.1038/onc.2014.15. Epub 2014 Mar 10.

Supplemental Content

Loading ...
Support Center